Danish Pharmacovigilance Update 19 December 2013

17 February 2014

In this issue of Danish Pharmacovigilance Update:

News from the EU

  • Restrictions on the use of metoclopramide (Primperan® etc.) for the treatment of nausea and vomiting
  • Letters of safety information sent to doctors

News from the Danish Health and Medicines Authority

  • Patients with mechanical heart valves should not be treated with the new oral anticoagulants Pradaxa®, Xarelto® and Eliquis®
  • Stricter reporting requirements for suspected adverse reactions following vaccination with Infanrix hexa®
  • Childhood vaccinations and reported suspected adverse reactions during the first half of 2013
  • Desmopressin and hyponatraemia
  • The Danish Health and Medicines Authority's analysis of melatonin users under the age of 25

Short news

  • New opportunity to report adverse reactions from dietary supplements to the Danish Veterinary and Food Administration
  • Clarification to the article 'Bisphosphonates/denosumab and the risk of osteonecrosis of the jaw' in Danish Pharmacovigilance Update, 28 November 2013

Did you get answers to your questions?

Please tell us how we can improve our website?